Research has shown that medical cannabis helps reduce hyperemesis, nausea, anorexia and pain by approximately 30 per cent, leading to significant improvements in patients’ quality of life and daily routines.
Medical cannabis has become an active component in therapeutic plans for both patients and doctors.
Scientific studies indicate that the human body’s endocannabinoid system plays a vital role in wellbeing.
The therapeutic strategy aims to enhance and support this system, which is affected by chronic conditions, to better manage disease-related symptoms and problems.
The treatment functions as a complementary and supportive therapy, particularly for pain management.
It works in conjunction with the body’s endogenous opioids and interacts positively with non-steroidal anti-inflammatory drugs, resulting in reduced opioid use.
Global literature on medical cannabis is extensive, demonstrating its broad potential.
Beyond oncologists, the treatment is utilised by other medical specialists, including rheumatologists, neurologists, and anaesthesiologists, to address chronic conditions such as spasticity and chronic pain.
(information from ygeiamou.gr)
